Xcout Intel
InMode
InMode Ltd. is a medical technology company that engineers, produces, and commercializes aesthetic medical devices globally, including within the United States. The firm's product portfolio is extensive, covering both less-invasive and non-surgical solutions. A core focus lies in their minimally invasive offerings, which leverage exclusive radiofrequency-assisted lipolysis (RFAL) and deep subdermal fractional radiofrequency technologies. These advanced devices facilitate a range of procedures, such as liposuction with concurrent skin firming, body and facial sculpting, intensive skin resurfacing treatments, and various women's health-related aesthetic interventions. Beyond these, InMode also provides non-invasive medical aesthetic products designed to address numerous cosmetic concerns. These include lasting hair removal, facial skin revitalization, the reduction of wrinkles, cellulite improvement, enhancing overall dermal quality and texture, and treating minor vascular and pigmented skin imperfections. Furthermore, the company develops automated, hands-free medical aesthetic systems for applications like dermal tightening, adipose tissue reduction, and muscular toning. Established in 2008, InMode Ltd. operates from its headquarters in Yokneam, Israel. The company was previously known as Invasix Ltd. before officially changing its name in November 2017.
Subscribe to see InMode’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
InMode at a glance
InMode is an aesthetics, medical technology company headquartered in Yokne'am, Israel, founded in 2008. It is publicly listed (INMD) with a market capitalisation of $863.4M. Xcout tracks 27 named people at InMode, including Moshe Mizrahy (Chief Executive Officer).
InMode leadership
- Moshe MizrahyChief Executive Officer
- Michael DennisonPresident of North America
- Moshe ItzkovichChief Financial Officer
- Moshik ItzkovichChief Financial Officer
- Dr. Michael KreindelChief Technology Officer
- Eran KriegerChief Medical Officer
21 more named people on record for InMode, with roles, board committees and tenure — see the full roster →
Recent InMode news
- AcquisitionInMode slips as unsolicited takeover bid expires (INMD:NASDAQ)
- Product launchInMode Advances RF Microneedling Comfort with the Launch of ...
- Product launchInMode Advances RF Microneedling Comfort with the Launch of ...
- AcquisitionSteel Partners Makes $16.75-Per-Share Cash Offer To Acquire InMode - Pulse 2.0
14 corporate events on record, with sources — see the full timeline →
InMode competitors
A few of InMode's closest competitors — see the full list of competitors and alternatives →
iMed Technology, Inc. is a US-based medical device manufacturer and business entity headquartered in Texas, specializing in single-use wound care and clinical products.
Epitomee Medical Ltd develops and commercializes ingestible therapeutic devices in Israel. The company offers capsules for the treatment of overweight and obesity. It also focuses on developing biologic drug delivery solutions. Epitomee Medical Ltd was incorporated in 2005 and is based in Caesarea, Israel.
Based in Or Yehuda, Israel, GlucoTrack, Inc. is a medical technology company focused on innovating, developing, and bringing to market non-invasive glucose monitoring systems. Their primary offering, the GlucoTrack device, enables individuals with diabetes or pre-diabetes to painlessly check their blood glucose levels. This technology is available to customers both in Israel and across the globe. The company, founded in 2001, operated under the name Integrity Applications, Inc. until it officially rebranded to GlucoTrack, Inc. in November 2021.
Illumigyn Ltd. is a medical equipment company that provides advanced colposcope systems, product design, and specialized women's health solutions.
IGEA S.p.A. is a medical technology company that develops and manufactures biophysical therapies for orthopedic applications, such as bone fracture healing and joint pathologies. The company also produces medical devices utilizing reversible electroporation for tumor treatments, vascular malformations, and gene therapies. Their products and devices are utilized by healthcare professionals and clinical institutions to serve patients requiring specialized medical treatments.
Pulsenmore Ltd. specializes in delivering self-scanning ultrasound technology for distant medical diagnosis and health screening throughout Israel and Europe. Its primary offering is the Pulsenmore at-home ultrasound system, which consists of a portable ultrasound unit that attaches to a patient's smartphone. An accompanying mobile application then securely uploads diagnostic images to the cloud for review. Furthermore, a specialized clinician dashboard enables medical professionals to examine stored video recordings or provide real-time guidance during a scan. Founded in 2014, the company is headquartered in Omer, Israel.
Get InMode's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on InMode in Xcout Intel
- 27 named people with titles, LinkedIn and board committees
- 14 corporate events with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access